High-Cost Pancreatic Cancer Drug Highlights Ongoing Inflation in Oncology Treatment Prices

Revolution Medicines' new pancreatic cancer treatment, priced at $480,000 annually, underscores the persistent surge in specialty drug costs over the past two decades.

31 Aug, 09:03 — 31 Aug, 09:03

Post Share

Sources

Showing 1 of 1 sources

NYTMostly Factual18h ago

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.

By Rebecca Robbins

Read full article →

High-Cost Pancreatic Cancer Drug Highlights Ongoing Inflation in Oncology Treatment Prices

Sources

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Related Stories

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue

Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases

England Pharmacies to Offer Free Quick Cholesterol Screening Tests